FinTrust Capital Advisors’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,400
Closed -$26.7K 1270
2023
Q3
$26.7K Sell
1,400
-1,500
-52% -$26K 0.01% 607
2023
Q2
$49K Hold
2,900
0.01% 450
2023
Q1
$49K Hold
2,900
0.01% 448
2022
Q4
$49K Sell
2,900
-1,100
-28% -$17.7K 0.01% 449
2022
Q3
$67K Hold
4,000
0.02% 452
2022
Q2
$46K Hold
4,000
0.01% 540
2022
Q1
$54K Hold
4,000
0.01% 545
2021
Q4
$53K Hold
4,000
0.01% 536
2021
Q3
$32K Hold
4,000
0.01% 629
2021
Q2
$27K Hold
4,000
0.01% 673
2021
Q1
$24K Hold
4,000
0.01% 668
2020
Q4
$13K Hold
4,000
﹤0.01% 771
2020
Q3
$10 Hold
4,000
﹤0.01% 801
2020
Q2
$9K Buy
+4,000
New +$8.55K ﹤0.01% 740

Other funds holding CLMT

FinTrust Capital Advisors's CLMT Position: Q4 2023 in Review

FinTrust Capital Advisors sold out of Calumet Specialty Products (CLMT) in Q4 2023, closing a stake of 1,400 shares — an estimated $26.7K sold.

FinTrust Capital Advisors first reported a position in CLMT in Q2 2020 and held it in 14 quarters. The position peaked at $67K in Q3 2022. 74 funds tracked by Wall St. Rank hold CLMT as of Q4 2023.

  • FinTrust Capital Advisors reported no remaining Calumet Specialty Products position as of Q4 2023 after selling out during the quarter.
  • FinTrust Capital Advisors sold 1,400 Calumet Specialty Products shares in Q4 2023, an estimated $26.7K.
  • FinTrust Capital Advisors first reported a position in Calumet Specialty Products in Q2 2020 and held it in 14 quarters.
  • FinTrust Capital Advisors's Calumet Specialty Products position peaked at $67K in Q3 2022.
  • 74 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q4 2023.

Based on FinTrust Capital Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.